DLAT Human

Dihydrolipoamide S-Acetyltransferase Human Recombinant
Cat. No.
BT3569
Source
Sf9 insect cells.
Synonyms
Dihydrolipoamide S-Acetyltransferase, PDC-E2, dihydrolipoyllysine-residue acetyltransferase component of pyruvate dehydrogenase complex mitochondrial, Pyruvate dehydrogenase complex component E2, 70 kDa mitochondrial autoantigen of primary biliary cirrhosis, DLAT, PBC, M2 antigen complex 70 kDa subunit, EC 2.3.1.12, EC 2.3.1.
Appearance
Sterile Filtered colorless solution.
Purity
DLAT purity was found to be greater than 75% as determined by SDS-PAGE.
Usage
Prospec's products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
Shipped with Ice Packs
In Stock

Description

DLAT is a full-length cDNA coding for the mature form of the human PDC-E2 protein having a molecular mass of 60,630 Dalton (pH 5.8). DLAT protein is fused to a hexa-histidine purification tag.

Product Specs

Introduction
The DLAT gene provides instructions for making the E2 component of the pyruvate dehydrogenase complex (PDC). This complex, found within the mitochondria, plays a crucial role in energy production by converting pyruvate to acetyl coenzyme A. Specifically, dihydrolipoamide acetyltransferase, the protein produced by the DLAT gene, transfers acetyl groups derived from pyruvate breakdown to coenzyme A. Autoimmune responses targeting this protein are a hallmark of primary biliary cirrhosis (PBC), a liver disease. In PBC, the immune system mistakenly attacks bile duct cells, where dihydrolipoamide acetyltransferase is overexpressed and abnormally distributed, leading to liver damage. Mutations in the DLAT gene can also cause pyruvate dehydrogenase E2 deficiency, a condition characterized by lactic acid buildup in infants and young children.
Description
This product consists of a full-length cDNA sequence that codes for the mature human PDC-E2 protein. This protein, with a molecular weight of 60,630 Daltons at a pH of 5.8, has been engineered to include a hexa-histidine tag for purification purposes.
Physical Appearance
The product is a clear, sterile-filtered solution.
Formulation

DLAT is supplied in a solution containing 20mM HEPES buffer (pH 8.0), 200mM NaCl, and 20% glycerol.

Stability

For short-term storage (2-4 weeks), DLAT should be kept at 4°C. For extended storage, it should be frozen at -20°C. Repeated freezing and thawing should be avoided.

Purity
Analysis by SDS-PAGE has determined that the purity of DLAT is greater than 75%.
Synonyms
Dihydrolipoamide S-Acetyltransferase, PDC-E2, dihydrolipoyllysine-residue acetyltransferase component of pyruvate dehydrogenase complex mitochondrial, Pyruvate dehydrogenase complex component E2, 70 kDa mitochondrial autoantigen of primary biliary cirrhosis, DLAT, PBC, M2 antigen complex 70 kDa subunit, EC 2.3.1.12, EC 2.3.1.
Source
Sf9 insect cells.

Product Science Overview

Structure and Function

DLAT is responsible for the acetyltransferase activity within the PDC. It accepts acetyl groups formed by the oxidative decarboxylation of pyruvate and transfers them to coenzyme A. This process is essential for the production of acetyl-CoA, a key molecule in the citric acid cycle, which is vital for energy production in cells .

The enzyme has distinct domains, including lipoyl, subunit-binding, and catalytic domains. These domains facilitate its function within the PDC, ensuring efficient catalysis of the necessary reactions .

Genetic and Clinical Significance

The gene encoding DLAT is located on chromosome 11 in humans. Mutations in this gene can lead to pyruvate dehydrogenase E2 deficiency, which causes primary lactic acidosis in infancy and early childhood . This condition is characterized by an inability to convert pyruvate to acetyl-CoA, leading to an accumulation of lactate in the body.

DLAT is also the antigen for antimitochondrial antibodies, which are present in nearly 95% of patients with primary biliary cirrhosis (PBC). PBC is an autoimmune liver disease where activated T lymphocytes attack and destroy epithelial cells in the bile duct, leading to cirrhosis and liver failure .

Recombinant DLAT

Recombinant DLAT is produced using genetic engineering techniques, where the DLAT gene is cloned and expressed in a suitable host organism, such as bacteria or yeast. This allows for the production of large quantities of the enzyme for research and therapeutic purposes.

Recombinant DLAT retains the functional properties of the native enzyme, making it a valuable tool for studying the enzyme’s role in metabolism and its involvement in various diseases. It is also used in the development of potential treatments for conditions associated with DLAT deficiency .

Research and Applications

Research on DLAT has provided insights into its structure, function, and role in cellular metabolism. Studies have shown that DLAT is crucial for the regulation of pyruvate metabolism and glycolysis, highlighting its importance in energy production .

Recombinant DLAT is used in various biochemical assays to study its activity and interactions with other components of the PDC. It is also employed in drug development to identify potential inhibitors or activators of the enzyme, which could be used to treat metabolic disorders .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.